Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BY 4.0Frontiers in Pharmacology

Neutrophil dysregulation in sepsis-induced acute lung injury: mechanistic framework and therapeutic targeting by natural products

4 affiliations
  1. 1Department of Anesthesiology, Guangxi Medical University Cancer Hospital
  2. 2Guangxi Engineering Research Center for Tissue & Organ Injury and Repair Medicine
  3. 3Guangxi Health Commission Key Laboratory of Basic Science and Prevention of Perioperative Organ Dysfunction
  4. 4Guangxi Clinical Research Center for Anesthesiology

Abstract

Sepsis-induced acute lung injury (SALI) is an important complication of sepsis associated with substantial morbidity and mortality, yet effective targeted therapies remain limited. Neutrophils are central effectors of innate immunity and play indispensable roles in early antimicrobial defense. However, during sepsis, persistent inflammatory stimulation drives neutrophil dysregulation, leading to excessive pulmonary infiltration, aberrant activation, delayed apoptosis, neutrophil extracellular trap (NET) formation, and immune imbalance, all of which contribute to alveolar-capillary barrier disruption and lung injury progression. Emerging evidence indicates that neutrophil heterogeneity in SALI is shaped by multiple molecular regulators rather than by maturation status alone. Trafficking receptors, activation-associated markers, disease-associated transcriptional states, and intercellular signaling pathways—including CXCR4, CXCR2, CD11b, CD16, CD177, Fth1, Prok2, CD64/CD271, PD-L1, and Notch1-related signaling—collectively regulate neutrophil trafficking, activation, effector responses, and crosstalk with endothelial and immune cells. In this review, we summarize the molecular determinants underlying neutrophil functional heterogeneity and discuss the dual role of neutrophils in host defense and tissue injury in SALI. We also highlight the major mechanisms of neutrophil-mediated lung damage and summarize emerging evidence that natural products can alleviate SALI by modulating neutrophil recruitment, oxidative stress, inflammatory signaling, and NET formation. Targeting neutrophil dysregulation represents a potential therapeutic approach that requires further mechanistic and clinical validation.

Related

  1. Neutrophil Extracellular Traps at the Asthma + COPD Interface: Mechanisms, Experimental Models, and Therapeutic Targeting
    Leandro do Nascimento Camargo, Renato Fraga Righetti, Iolanda de Fátima Lopes Calvo Tibério
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  2. Neutrophils and Neutrophil Extracellular Traps in Cancer and Cardio-Oncology: Molecular Mechanisms, Therapeutic Targeting, and Clinical Perspectives.
    Melpomeni Maria Panou, Kallirroi Kalantzi, Despoina Pantazi
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textImmunologyEurope PMC
  3. Mapping neutrophil membrane bioactivity to therapeutic interfaces: Biology, disease targeting, and activity-guided biomimetic therapy.
    Qingqing Yang, Mingjing Leng, Wenbi Jiang +7
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textImmunologyEurope PMCPMC
  4. Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline
    Mohammed Nabil Quraishi, Vipul Jairath, Badr Al-Bawardy
    Inflammatory Bowel DiseasesPeer-reviewedCC BY 4.0Full textGenetics & genomicsPMC
  5. From CAF heterogeneity to immune modulation and therapeutic targeting: a subtype-based framework
    Tianen Zhang, Shisong Jiang
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
BibTeX
@article{luo2026neutrophil,
  title = {{Neutrophil dysregulation in sepsis-induced acute lung injury: mechanistic framework and therapeutic targeting by natural products}},
  author = {Huilin Luo and Jinyuan Lin and Honglei Shen and Dongqin Huang and Maoyao Ling and Liu Ye},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  month = oct,
  doi = {10.3389/fphar.2026.1925322},
  url = {https://www.frontiersin.org/articles/10.3389/fphar.2026.1925322/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Neutrophil dysregulation in sepsis-induced acute lung injury: mechanistic framework and therapeutic targeting by natural products
AU  - Huilin Luo
AU  - Jinyuan Lin
AU  - Honglei Shen
AU  - Dongqin Huang
AU  - Maoyao Ling
AU  - Liu Ye
PY  - 2026
DA  - 2026/10/14
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1925322
UR  - https://www.frontiersin.org/articles/10.3389/fphar.2026.1925322/full
AB  - Sepsis-induced acute lung injury (SALI) is an important complication of sepsis associated with substantial morbidity and mortality, yet effective targeted therapies remain limited. Neutrophils are central effectors of innate immunity and play indispensable roles in early antimicrobial defense. However, during sepsis, persistent inflammatory stimulation drives neutrophil dysregulation, leading to excessive pulmonary infiltration, aberrant activation, delayed apoptosis, neutrophil extracellular trap (NET) formation, and immune imbalance, all of which contribute to alveolar-capillary barrier disruption and lung injury progression. Emerging evidence indicates that neutrophil heterogeneity in SALI is shaped by multiple molecular regulators rather than by maturation status alone. Trafficking receptors, activation-associated markers, disease-associated transcriptional states, and intercellular signaling pathways—including CXCR4, CXCR2, CD11b, CD16, CD177, Fth1, Prok2, CD64/CD271, PD-L1, and Notch1-related signaling—collectively regulate neutrophil trafficking, activation, effector responses, and crosstalk with endothelial and immune cells. In this review, we summarize the molecular determinants underlying neutrophil functional heterogeneity and discuss the dual role of neutrophils in host defense and tissue injury in SALI. We also highlight the major mechanisms of neutrophil-mediated lung damage and summarize emerging evidence that natural products can alleviate SALI by modulating neutrophil recruitment, oxidative stress, inflammatory signaling, and NET formation. Targeting neutrophil dysregulation represents a potential therapeutic approach that requires further mechanistic and clinical validation.
SN  - 1663-9812
ER  -